Attention Deficit Hyperactivity Disorder

State of the evidence

ADHD is established as a neurodevelopmental disorder defined by inattention, hyperactivity, and impulsivity 1,5. Evidence indicates a strong genetic component involving 27 risk loci and midbrain dopaminergic neurons 2, with theoretical models suggesting that dopaminergic dysfunction leads to delay aversion 5. While prevalence is high in children 1,3,6, there is significant evidence of underrepresentation in females, who often present with inattention and internalizing problems rather than hyperactivity 4. There is ongoing debate regarding 'late-onset' ADHD, with some evidence suggesting these cases may be misattributed symptoms of other psychiatric conditions 9.

Key findings

• ADHD genetic risk is linked to early brain development and midbrain dopaminergic neurons 2. 2
• Females are diagnosed at lower rates than males in childhood, but the gap narrows by adulthood, with females showing a predominance of inattention 4. 4
• A hypofunctioning mesolimbic dopamine branch may cause delay aversion and deficient extinction of reinforced behavior 5. 5
• Data-driven clustering suggests that ADHD symptoms (inattention/hyperactivity) are common across various neurodevelopmental disorders, supporting a transdiagnostic approach 7. 7
• Longitudinal assessments challenge the validity of 'late-onset' ADHD, suggesting symptoms in young adults often lack childhood precursors 9. 9

Where the evidence disagrees

• The existence of 'late-onset' ADHD is contested; some evidence suggests these are alternative psychiatric causes rather than a distinct ADHD onset 9.
• Diagnostic criteria are behavioral, but research suggests these labels may not reflect underlying biological realities, favoring a transdiagnostic approach 7.

Open opportunities

What the research supports that no idea in the catalog takes yet.

• Female-Specific ADHD Screening and Diagnostic Support Tool

  Evidence shows females are underrepresented and present with internalizing/inattentive symptoms that differ from the male-centric diagnostic norm 4.

• Genetic-Risk Stratification Tool for Treatment Response

  The identification of 27 risk loci and specific neuronal subtypes 2 provides a biological basis for personalizing pharmacological interventions.

• Transdiagnostic Neurodevelopmental Profiling Tool

  Since ADHD symptoms overlap heavily with autism and OCD 7, a tool that maps cortical morphology and social skills across labels could improve intervention.

References

1. 1.The global prevalence of ADHD in children and adolescents: a systematic review and meta-analysisNader Salari, Hooman Ghasemi, Nasrin Abdoli et al. · 2023 · 663 citations
2. 2.Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domainsDitte Demontis, G. Bragi Walters, Georgios I. Athanasiadis et al. · 2023 · 828 citations
3. 3.The global prevalence of attention deficit hyperactivity disorder in children and adolescents: An umbrella review of meta-analysesGetinet Ayano, Sileshi Demelash, Yitbarek Gizachew et al. · 2023 · 452 citations
4. 4.Annual Research Review: Attention‐deficit/hyperactivity disorder in girls and women: underrepresentation, longitudinal processes, and key directionsStephen P. Hinshaw, Phuc T. Nguyen, Sinclaire M. O’Grady et al. · 2021 · 435 citations
5. 5.a dynamic developmental theory of attention-deficit/hyperactivity disorder (adhd) predominantly hyperactive/impulsive and combined subtypesTerje Sagvolden, Espen Borgå Johansen, Heidi Aase et al. · 2005 · 1042 citations
6. 6.Current state of knowledge on the prevalence of neurodevelopmental disorders in childhood according to the DSM-5: a systematic review in accordance with the PRISMA criteriaLorena Francés, Javier Quintero, Alberto Fernández et al. · 2022 · 353 citations
7. 7.Annual Research Review: The transdiagnostic revolution in neurodevelopmental disordersDuncan Edward Astle, Joni Holmes, Rogier Kievit et al. · 2021 · 394 citations
8. 8.Price of Adaptation—Allostatic Load and Its Health ConsequencesTeresa E. Seeman · 1997 · 1375 citations
9. 9.Late-Onset ADHD Reconsidered With Comprehensive Repeated Assessments Between Ages 10 and 25Margaret H. Sibley, Luís Augusto Rohde, James M. Swanson et al. · 2017 · 166 citations
10. 10.Early intervention in psychosis: concepts, evidence and future directionsPatrick D. McGorry, Eóin Killackey, Alison R. Yung · 2008 · 583 citations